Replies to post #4868 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Notes on Pharming Group, N.V.

#msg-25275659 EMEA rejects Rhucin for HAE
#msg-17760532 Musings by ‘rustyboy’ (precedes Rhucin news above)
#msg-20830051 Pipeline overview
#msg-22208171 Phase-3 Rhucin data
#msg-22482530 Pharming seeks US partner
#msg-18949245 IP cross-license with GTC